Safety and Effectiveness of Ferumoxytol in Hemodialysis Patients at 3 Dialysis Chains in the United States Over a 12-Month Period
- 1 January 2014
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 36 (1) , 70-83
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- FerumoxytolDrugs, 2012
- When is high-dose intravenous iron repletion needed? Assessing new treatment optionsDrug Design, Development and Therapy, 2011
- Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?Current Medical Research and Opinion, 2009
- Physicochemical properties of ferumoxytol, a new intravenous iron preparationEuropean Journal of Clinical Investigation, 2009
- Ferumoxytol as an Intravenous Iron Replacement Therapy in Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2009
- Safety of Ferumoxytol in Patients With Anemia and CKDAmerican Journal of Kidney Diseases, 2008
- Ferumoxytol for Treating Iron Deficiency Anemia in CKDJournal of the American Society of Nephrology, 2008
- The Comparative Safety of Various Intravenous Iron Preparations in Chronic Kidney Disease PatientsRenal Failure, 2008
- Treating anemia of chronic kidney disease in the primary care setting: cardiovascular outcomes and management recommendationsOsteopathic Medicine and Primary Care, 2007
- Anemia in chronic kidney disease: causes, diagnosis, treatment.Cleveland Clinic Journal of Medicine, 2006